2012
Towards new treatment options for renal cell carcinoma: Development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor
Publication
Publication
Translational Andrology and Urology , Volume 1 - Issue 4 p. 207- 208
| Additional Metadata | |
|---|---|
| doi.org/10.3978/j.issn.2223-4683.2012.06.02, hdl.handle.net/1765/52629 | |
| Translational Andrology and Urology | |
| Organisation | Department of Medical Oncology |
|
Eskens, F., & Haberkorn, B. (2012). Towards new treatment options for renal cell carcinoma: Development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor. Translational Andrology and Urology, 1(4), 207–208. doi:10.3978/j.issn.2223-4683.2012.06.02 |
|